A coronary calcium score is the fastest way we know to replace a probability with a measurement. Everything else in cardiovascular prevention, risk calculators, cholesterol panels, blood pressure averages, is an estimate of what might be building inside your arteries. The calcium scan is a few minutes in a CT machine, no needles, no dye, roughly $100 to $400 out of pocket for most people, and it answers a different question: how much plaque is actually there, right now. In our cardiometabolic practice, built around treating metabolic, hormonal and cardiovascular health as one system, we treat this scan as one of the most information-dense purchases in medicine. Here is what it measures, what it costs, why a normal cholesterol result does not protect you the way most people assume, and where the scan fits inside our Cardiometabolic Optimization membership.
- A coronary calcium score is a low-dose CT scan that measures calcified plaque directly; a score of zero is genuinely reassuring in the right patient.
- Most insurance, including Original Medicare, typically does not cover the scan; self-pay estimates run roughly $100 to $400 (GoodRx, June 2026).
- Normal cholesterol is not clearance: in a study of 136,905 heart-disease hospitalizations, average admission LDL was 104.9 mg/dL, inside the range most labs call normal.
- The scan changes real decisions, when to start a statin, how hard to push ApoB down, how closely to re-check.
- Blood-panel biomarkers and imaging answer different questions, and the strongest risk picture uses both.
The question the scan answers that a calculator cannot
Risk calculators have an uncomfortable property: they are built on populations, and you are one person. A tool can tell you that someone with your numbers, on average, carries a twelve percent ten-year risk. What it cannot tell you is whether the process that produces heart attacks, plaque accumulating inside the walls of your coronary arteries, has already started in your body. Two people with identical lipid panels can sit at opposite ends of that reality.
The calcium score closes most of that gap. Calcified plaque is what CT sees, and the amount of it tracks closely with the total plaque burden, including the soft, rupture-prone plaque that causes events. That is the clinical logic behind using it: not that calcium itself is the danger, but that it is the visible footprint of everything else.
What each part of the risk picture tells you
| Tool | What it measures | What it misses | ||
|---|---|---|---|---|
| --- | --- | --- | ||
| Standard lipid panel | Cholesterol carried in LDL and HDL | Particle number, actual plaque | ||
| ApoB and Lp(a) | The number of atherogenic particles; inherited risk | Whether plaque has already formed | ||
| Risk calculators | Population-based probability | Whether it applies to you specifically | ||
| Coronary calcium score | Calcified plaque, measured directly | Non-calcified plaque, and it says nothing about why plaque formed |
Why 'my cholesterol is normal' is not the reassurance it feels like
This deserves its own section, because it is the objection we hear most from new members and the one the medical literature answers most bluntly. In 2009, a team analyzing 136,905 hospitalizations for coronary artery disease across 541 US hospitals reported something that unsettled the standard lipid targets of the time: the average LDL cholesterol on admission was 104.9 mg/dL, well inside the range most primary care visits call normal, and fewer than one in five patients had LDL below 70. Only 1.4% had what the researchers called ideal levels. The full paper is available here.
Read that again from the patient's chair: roughly half of the people in those hospital beds had spent years being told their cholesterol was fine. The lesson is not that cholesterol does not matter; it is that the standard panel measures the wrong unit for the job, cholesterol mass instead of particle number, and that a single snapshot misses everything about trend and time. Particle-number testing (ApoB, and Lp(a) once in a lifetime because it is largely genetic) plus imaging is how the picture becomes three-dimensional. We explain the difference in plain terms in our guide to ApoB and in the advanced labs that go beyond a lipid panel.
What the scan actually is, and what it costs
The procedure is uneventful by design. You lie on a CT table, hold still for a few minutes while a low-dose scan images your heart between beats, and go back to your day. No contrast, no fasting, no recovery. The output is a single Agatston score: zero, or a number that climbs with plaque volume.
On cost, the honest framing is that the scan sits in a coverage gray zone. Because it is usually ordered for screening in asymptomatic people, most commercial plans and Original Medicare typically do not pay for it, which is why the self-pay market exists and why prices are visible enough to comparison-shop. GoodRx's published estimates put a coronary artery calcium scan at roughly $100 to $400, with many facilities clustering near $100 to $150, and some hospital heart-scan programs listing lower promotional prices; their guidance and caveats are here. Prices vary by region and by whether an interpreting radiologist's fee is added, so the practical advice stands regardless of what you pay: ask for the cash price and whether an order is needed before you book.
We want to be equally plain about what that number buys relative to everything else in longevity medicine. Against a $20,000 executive diagnostic program that ends in a binder of results and no treatment plan, a $150 scan read by a clinician who will actually change your prescriptions is arguably the best value in the entire category. We make that comparison carefully and with hedged, sourced numbers in our review of what executive health programs cost, because the difference is not price, it is what happens after the results arrive.
How we use the score inside the membership
The scan is not part of our included Biomarker Audit, and we want that stated without hedging, because trust in this industry dies in small print. The Audit is the blood panel, ApoB, Lp(a), hs-CRP, HbA1c, insulin markers, the full hormone and thyroid set, drawn every 90 days and included in the membership. Imaging is ordered when the clinical picture calls for it and billed by the facility at its own price; what we contribute is the judgment around it. The structural reasoning is in Aligned Medicine and the zero-markup model: we make money on the care relationship, not on volume of tests, so we order the scan when it changes something and skip it when it does not.
- Score of zero in an intermediate-risk patient: near-term reassurance; statin decision can often wait, re-check with ApoB on the next Audit cycle. - Low score with high ApoB: the particles are the problem even if plaque is early; aggressive lipid lowering becomes the priority. - Moderate to high score: the conversation shifts from prevention to active treatment, with the score repeated only years later, not annually.
That third row matters. A high score does not mean the scan gets repeated yearly; plaque burden measured once guides a decade of decisions, and repeating the scan too soon mostly generates anxiety and invoices.
Who should get one, and who should not
The scan is most useful for adults roughly 40 to 75 without a known coronary disease diagnosis, whose risk sits in the uncomfortable middle: too high to ignore, not so high that treatment is already obvious. If you have already had a heart attack, a stent or bypass surgery, the scan adds little; your treatment is already where it needs to be aggressive. If you are very young with a strong family history, the priority is usually ApoB and Lp(a) testing first, because plaque calcifies with time and a zero at 32 means less than a zero at 58.
What we do not recommend is treating the scan as a standalone purchase with no clinician attached. A number without interpretation is a coin toss with extra steps. We have written about this pattern directly in why paying only for labs leaves the decision unmade: the scan is the cheap part; the decades of correctly-calibrated treatment it unlocks is the value, and that part requires a clinician who knows your whole metabolic picture.
One flat fee for the doctor. Zero markup on the medicine.
The wider point: cardiometabolic risk is one system, not a cardiology folder
A high calcium score is the end of a story that usually started years earlier: rising HbA1c, creeping insulin resistance, a thyroid drifting below where it should be, inflammation nobody measured, all moving together because in the body they are one system. That is the whole premise of Cardiometabolic Optimization as we define it: measure the system, treat the system, and let imaging confirm what the biomarkers predicted rather than discovering it too late.
If your annual physical has produced only 'normal' and a growing sense that something is being missed, the sequence we recommend is simple: get the ApoB and Lp(a) numbers first, have a clinician read them with your history in hand, and let that conversation decide whether the scan belongs in your picture. Then the $150 becomes what it should be: the measurement that either buys you years of confidence or redirects your treatment before the plaque becomes the diagnosis.
FAQ
What is a coronary calcium score? A low-dose CT scan that measures calcified plaque in your coronary arteries as a single number. Zero usually means no detectable calcified plaque and very low near-term risk; higher scores mean established plaque and a changed treatment conversation.
How much does it cost out of pocket? Most insurance and Original Medicare typically do not cover screening use. Published self-pay estimates run about $100 to $400, with many facilities near $100 to $150 (GoodRx, June 2026). Ask for the cash price and whether an order is needed before booking.
Does normal cholesterol mean my arteries are clear? No. In 136,905 heart-disease hospitalizations, average admission LDL was 104.9 mg/dL, inside the normal range, and only 1.4% of patients had ideal levels. A standard panel is a starting point, not clearance.
What does a score of zero mean? In the right patient, it is genuinely reassuring for near-term risk and can defer preventive medication decisions. It does not rule out soft plaque and does not override a high ApoB or family history, so it is read with the full panel, never alone.
Does the membership include imaging? The included Biomarker Audit is the blood panel every 90 days. Imaging is ordered when the risk picture calls for it and billed by the facility at its own price, with our clinicians interpreting the result inside your plan.
How often is the scan repeated? Plaque burden measured once guides years of decisions. Repeat scanning is typically reserved for intervals of years or for specific clinical questions, not annual reassurance.
Sources
- Sachdeva et al., "Lipid levels in patients hospitalized with coronary artery disease", American Heart Journal, 2009 (136,905 hospitalizations)
- GoodRx, "Coronary Artery Calcium Scan Cost and Savings Tips", published estimates June 2026 (goodrx.com)